Onconetix, Inc. – NASDAQ:ONCO
Onconetix stock price today
Onconetix stock price monthly change
Onconetix stock price quarterly change
Onconetix key metrics
Market Cap | 2.92M |
Enterprise value | N/A |
P/E | N/A |
EV/Sales | N/A |
EV/EBITDA | N/A |
Price/Sales | N/A |
Price/Book | N/A |
PEG ratio | N/A |
EPS | -2.24 |
Revenue | N/A |
EBITDA | -16.37M |
Income | -45.68M |
Revenue Q/Q | N/A |
Revenue Y/Y | N/A |
Profit margin | 0% |
Oper. margin | 0% |
Gross margin | 0% |
EBIT margin | 0% |
EBITDA margin | N/A |
create your own Smart Feed
Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.
Sign up for freeOnconetix stock price history
Onconetix stock forecast
Onconetix financial statements
| Jun 2023 | 0 | -6.86M | |
|---|---|---|---|
| Sep 2023 | 0 | -5.34M | |
| Dec 2023 | 58.46K | -22.35M | -38229.49% |
| Mar 2024 | 700.43K | -11.11M | -1587.39% |
| 2027 | 58.46K | -21.56M | -36877.33% |
|---|
Analysts Price target
Financials & Ratios estimates
| Jun 2023 | 29747515 | 16.67M | 56.04% |
|---|---|---|---|
| Sep 2023 | 27881871 | 17.64M | 63.29% |
| Dec 2023 | 88821449 | 23.18M | 26.1% |
| Mar 2024 | 75031599 | 25.29M | 33.71% |
| Jun 2023 | -1.78M | -10.03M | -214.66K |
|---|---|---|---|
| Sep 2023 | -3.04M | 173.01K | 1.29M |
| Dec 2023 | -4.31M | 1.21M | 0 |
| Mar 2024 | -5.23M | -4.57K | 5.20M |
Onconetix alternative data
| Jun 2024 | 12 |
|---|---|
| Jul 2024 | 12 |
Onconetix other data
-
What's the price of Onconetix stock today?
One share of Onconetix stock can currently be purchased for approximately $2.86.
-
When is Onconetix's next earnings date?
Unfortunately, Onconetix's (ONCO) next earnings date is currently unknown.
-
Does Onconetix pay dividends?
No, Onconetix does not pay dividends.
-
How much money does Onconetix make?
Onconetix has a market capitalization of 2.92M.
-
What is Onconetix's stock symbol?
Onconetix, Inc. is traded on the NASDAQ under the ticker symbol "ONCO".
-
What is Onconetix's primary industry?
Company operates in the Healthcare sector and Biotechnology industry.
-
How do i buy shares of Onconetix?
Shares of Onconetix can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
-
How many employees does Onconetix have?
As Jul 2024, Onconetix employs 12 workers.
-
When Onconetix went public?
Onconetix, Inc. is publicly traded company for more then 3 years since IPO on 18 Feb 2022.
-
What is Onconetix's official website?
The official website for Onconetix is onconetix.gcs-web.com.
-
Where are Onconetix's headquarters?
Onconetix is headquartered at 201 East Fifth Street, Cincinnati, OH.
-
How can i contact Onconetix?
Onconetix's mailing address is 201 East Fifth Street, Cincinnati, OH and company can be reached via phone at +51 36204101.
Onconetix company profile:
Onconetix, Inc.
onconetix.gcs-web.comNASDAQ
12
Biotechnology
Healthcare
Onconetix, Inc., a biotechnology and pharmaceutical company, focuses on developing and commercializing transformational therapies to address health challenges worldwide. The company owns Entadfi, an FDA-approved, once daily pill that combines finasteride and tadalafil for the treatment of benign prostatic hyperplasia. It is also developing a streptococcus pneumoniae vaccine candidate, which is designed to prevent infectious middle ear infections in children, and prevention of pneumonia in the elderly; and universal flu vaccine that provide protection from all virulent strains in addition to licensing a novel norovirus S&P nanoparticle versatile virus-like particle vaccine platform from Cincinnati Children's to develop vaccines for multiple infectious diseases, including Marburg and monkeypox, and others. The company was formerly known as Blue Water Biotech, Inc. and changed its name to Onconetix, Inc. in December 2023. Onconetix, Inc. was incorporated in 2018 and is headquartered in Cincinnati, Ohio.
Cincinnati, OH 45202
CIK: 0001782107
ISIN: US09610B1089
:
